VANFLYTA® First FLT3 Inhibitor Approved in the U.S. Specifically for Patients with Newly Diagnosed FLT3-ITD Positive AML
First and only FLT3 inhibitor approved across three phases of AML treatment based on QuANTUM-First…
First and only FLT3 inhibitor approved across three phases of AML treatment based on QuANTUM-First…
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--#crypto--Today, Modulus, a US-based developer of ultra-high-performance trading and surveillance technology that powers…
SINGAPORE--(BUSINESS WIRE)--ONE Championship, the world’s largest martial arts organization, today announced that the promotion will…
DUBLIN--(BUSINESS WIRE)--The "Southeast Asia Data Center Market - Focused Insights 2023-2028" report has been added…
Strong financial performance underscores the demand for prioritization and productivity improvements across digitalization initiatives AUSTIN,…
PowerSchool’s partnership with Samart Telcoms PCL will expand educator and student access to PowerSchool’s innovative…
Collaboration will explore trans-arterial delivery of Imugene’s CF33 oncolytic virus utilizing RenovoRx’s TAMP therapy platform.…
A Structured Cybersecurity Management System Ensures Holistic Cybersecurity Practices Across The Entire Device Life Cycle…
Collaboration Is First-Ever Between Ministry of Foreign Affairs and a Commercial Provider of Policy, Regulatory,…
MANILA, Philippines--(BUSINESS WIRE)--Consumer fintech Salmon today announces it has secured a USD 20MM debt facility…